SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211374
Filing Date
2013-05-09
Accepted
2013-05-09 17:05:03
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d508920d10q.htm 10-Q 971404
2 EX-31.1 d508920dex311.htm EX-31.1 6693
3 EX-31.2 d508920dex312.htm EX-31.2 6756
4 EX-32.1 d508920dex321.htm EX-32.1 3258
5 EX-32.2 d508920dex322.htm EX-32.2 3001
  Complete submission text file 0001193125-13-211374.txt   9772306

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mrk-20130331.xml EX-101.INS 1944638
7 XBRL TAXONOMY EXTENSION SCHEMA mrk-20130331.xsd EX-101.SCH 76019
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrk-20130331_cal.xml EX-101.CAL 105863
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20130331_def.xml EX-101.DEF 233071
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20130331_lab.xml EX-101.LAB 562493
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20130331_pre.xml EX-101.PRE 415947
Mailing Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 908-423-4840
Merck & Co. Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 13829805
SIC: 2834 Pharmaceutical Preparations